• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.腹膜透析患者腹腔内注射头孢唑林的药理学
Antimicrob Agents Chemother. 1978 Sep;14(3):318-21. doi: 10.1128/AAC.14.3.318.
2
Effects of renal failure and dialysis on cefazolin pharmacokinetics.肾衰竭和透析对头孢唑林药代动力学的影响。
Antimicrob Agents Chemother. 1975 Jul;8(1):63-6. doi: 10.1128/AAC.8.1.63.
3
Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.腹膜透析患者中短驻留周期腹腔内注射头孢唑林加头孢他啶
Perit Dial Int. 2017 Mar-Apr;37(2):218-224. doi: 10.3747/pdi.2015.00300. Epub 2016 Oct 13.
4
Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis.在腹膜透析相关性腹膜炎患者进行短期留存换液期间腹腔内使用头孢唑林和头孢他啶。
Perit Dial Int. 2020 Mar;40(2):179-184. doi: 10.1177/0896860819893820. Epub 2020 Jan 17.
5
[The geriatric pharmacology of cefazolin, cefradin and sulfisomidine].
Arzneimittelforschung. 1976;26(7):1377-82.
6
Pharmacokinetic study of cefazaflur compared to cephalothin and cefazolin.头孢唑氟与头孢噻吩及头孢唑林的药代动力学研究。
J Clin Pharmacol. 1977 Feb-Mar;17(2-3):128-33. doi: 10.1002/j.1552-4604.1977.tb04599.x.
7
Cefazolin and cephalexin kinetics in continuous ambulatory peritoneal dialysis.
Clin Pharmacol Ther. 1983 Jan;33(1):66-72. doi: 10.1038/clpt.1983.9.
8
Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.持续非卧床腹膜透析患者间歇性腹腔注射头孢唑林的药代动力学
Perit Dial Int. 1999 Jan-Feb;19(1):65-70.
9
Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.接受自动化腹膜透析治疗的患者间歇性静脉注射头孢唑林和妥布霉素的药代动力学
J Am Soc Nephrol. 2000 Jul;11(7):1310-1316. doi: 10.1681/ASN.V1171310.
10
Pharmacokinetics of ceftazidime in patients undergoing peritoneal dialysis.
J Antimicrob Chemother. 1983 Jul;12 Suppl A:263-7. doi: 10.1093/jac/12.suppl_a.263.

引用本文的文献

1
Peritoneal absorption of moxalactam.莫西拉坦的腹膜吸收
Antimicrob Agents Chemother. 1983 Jul;24(1):39-41. doi: 10.1128/AAC.24.1.39.
2
Drug therapy in patients undergoing peritoneal dialysis. Clinical pharmacokinetic considerations.接受腹膜透析患者的药物治疗。临床药代动力学考量
Clin Pharmacokinet. 1985 Sep-Oct;10(5):404-25. doi: 10.2165/00003088-198510050-00003.

本文引用的文献

1
The passage of cephalothin into and out of ascitic fluid.
Am J Med Sci. 1967 Apr;253(4):449-52. doi: 10.1097/00000441-196704000-00007.
2
Irrigation of the peritoneal cavity with cephalothin.
Am J Surg. 1972 Feb;123(2):192-5. doi: 10.1016/0002-9610(72)90332-7.
3
Pharmacokinetics of cefazolin in normal and uremic subjects.头孢唑林在正常受试者和尿毒症受试者中的药代动力学。
Clin Pharmacol Ther. 1974 Apr;15(4):344-53. doi: 10.1002/cpt1974154344.
4
Clinical and in vitro evaluation of cefazolin, a new cephalosporin antibiotic.新型头孢菌素抗生素头孢唑林的临床及体外评价
Antimicrob Agents Chemother. 1973 Feb;3(2):168-74. doi: 10.1128/AAC.3.2.168.
5
Pharmacodynamics of cefazolin in the presence of normal and impaired renal function.头孢唑林在肾功能正常和受损情况下的药效学
Antimicrob Agents Chemother. 1973 Sep;4(3):366-71. doi: 10.1128/AAC.4.3.366.
6
Pharmacology of cefazolin in patients with normal and abnormal renal function.
J Infect Dis. 1973 Oct;128:Suppl:S354-7. doi: 10.1093/infdis/128.supplement_2.s354.
7
Prophylaxis with cephalothin in peritoneal dialysis.
Arch Intern Med. 1973 Sep;132(3):368-71.
8
Effects of renal failure and dialysis on cefazolin pharmacokinetics.肾衰竭和透析对头孢唑林药代动力学的影响。
Antimicrob Agents Chemother. 1975 Jul;8(1):63-6. doi: 10.1128/AAC.8.1.63.
9
Prolonged antibiotic peritoneal lavage in the management of gross generalized peritonitis.
Med J Aust. 1976 Jun 19;1(25):954-6.

腹膜透析患者腹腔内注射头孢唑林的药理学

Pharmacology of intraperitoneal cefazolin in patients undergoing peritoneal dialysis.

作者信息

Kaye D, Wenger N, Agarwal B

出版信息

Antimicrob Agents Chemother. 1978 Sep;14(3):318-21. doi: 10.1128/AAC.14.3.318.

DOI:10.1128/AAC.14.3.318
PMID:708010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC352457/
Abstract

Cefazolin was added to dialysis fluid in nine patients with renal failure undergoing peritoneal dialysis with 2 liters/h per exchange. With 50 mg/liter (three patients), the first measurable mean serum concentration was 3.7 mug/ml (range, 2.4 to 4.9 mug/ml) after three exchanges and was 30.3 mug/ml (range, 13.3 to 44.3 mug/ml) after 24 exchanges. After 18 to 24 more exchanges without cefazolin, the mean serum concentration was 12.3 mug/ml (range, 3.8 to 24.6 mug/ml). The mean concentration in the dialysis outflow was 26.9 mug/ml (range, 2.5 to 58.5 mug/ml). With 150 mg/liter (six patients), the mean serum concentration was 5.2 mug/ml (range, 3.6 to 7.8 mug/ml) after the first exchange and 8.4 (range, 6.1 to 14.0 mug/ml), 15.0 (range, 8.2 to 23.5 mug/ml), and 71.9 (range, 26.2 to 142.1 mug/ml) mug/ml after the second, third, and twenty-fourth exchanges, respectively. After 17 to 24 more exchanges without cefazolin, the mean serum concentration was 38.2 mug/ml (range, 15.4 to 65.7 mug/ml). The mean concentration in the dialysis outflow was 71.4 mug/ml (range, 21.9 to 150.8 mug/ml). After 1 g of cefazolin was given intraperitoneally with no more dialysis, serum concentrations rose by a mean of 62.5 mug/ml (range, 18.9 to 107.8 mug/ml). The maximum rise occurred within 2 h with two-thirds of the rise occurring within 30 min. During the subsequent 22 h levels dropped to 65.4% of the peak.

摘要

9例接受腹膜透析的肾衰竭患者,透析液交换速度为每小时2升,在透析液中加入头孢唑林。对于每升含50毫克头孢唑林的情况(3例患者),三次交换后首个可测的平均血清浓度为3.7微克/毫升(范围为2.4至4.9微克/毫升),24次交换后为30.3微克/毫升(范围为13.3至44.3微克/毫升)。在未添加头孢唑林再进行18至24次交换后,平均血清浓度为12.3微克/毫升(范围为3.8至24.6微克/毫升)。透析流出液中的平均浓度为26.9微克/毫升(范围为2.5至58.5微克/毫升)。对于每升含150毫克头孢唑林的情况(6例患者),首次交换后平均血清浓度为5.2微克/毫升(范围为3.6至7.8微克/毫升),第二次、第三次和第二十四次交换后分别为8.4(范围为6.1至14.0微克/毫升)、15.0(范围为8.2至23.5微克/毫升)和71.9(范围为26.2至142.1微克/毫升)微克/毫升。在未添加头孢唑林再进行17至24次交换后,平均血清浓度为38.2微克/毫升(范围为15.4至65.7微克/毫升)。透析流出液中的平均浓度为71.4微克/毫升(范围为21.9至150.8微克/毫升)。腹腔内给予1克头孢唑林且不再进行透析后,血清浓度平均升高62.5微克/毫升(范围为18.9至107.8微克/毫升)。最大升幅在2小时内出现,三分之二的升幅在30分钟内出现。在随后的22小时内,水平降至峰值的65.4%。